Reintervention Rate After Pigtail Catheter Insertion Compared to Surgical Chest Tubes

医学 血胸 气胸 胸导管 外科 胸腔积液 导管 渗出 胸腔造口术 放射科 胸痛 胸膜疾病 回顾性队列研究 呼吸道疾病 内科学
作者
Keith D. Mortman,Mira T. Tanenbaum,Kathryn M. Cavallo,Devon Kelley,Stephano S. Bonitto,Alana Sadur,Richard Amdur,Shawn Sarin,Michael A. Napolitano
出处
期刊:American Surgeon [SAGE Publishing]
卷期号:89 (12): 5487-5491 被引量:2
标识
DOI:10.1177/00031348231157419
摘要

Background Prior studies suggest similar efficacy between large-bore chest tube (CT) placement and small-bore pigtail catheter (PC) placement for the treatment of pleural space processes. This study examined reintervention rates of CT and PC in patients with pneumothorax, hemothorax, and pleural effusion. Methods This retrospective study examined patients from September 2015 through December 2020. Patients were identified using ICD codes for pneumothorax, hemothorax, or pleural effusion. Use of a pigtail catheter (≤14Fr) or surgical chest tube (≥20Fr) was noted. The primary outcome was overall reintervention rate within 30 days of tube insertion. Patients who died with a pleural drainage catheter in place, unrelated to complications from chest tube placement, were excluded. Results There were 1032 total patients in the study: 706 CT patients and 326 PC patients. The PC group was older with more comorbidities and more likely to have effusion as the indication for pleural drainage. Patients with PC were 2.35 times more likely to have the tube replaced or repositioned ( P < .0001), 1.77 times more likely to require any reintervention ( P = .001) and 2.09 times more likely to remain in the hospital >14 days ( P < .0001) compared to patients with CT. Conclusion PCs have a significantly higher reintervention rate compared to CT for the treatment of pneumothorax, hemothorax, and pleural effusion. Although PC are believed to cause less pain and tissue trauma, they do not necessarily drain the pleural space as well as CT. Decisions on which method of draining the chest should be made on a case-by-case basis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
赘婿应助聪慧芷巧采纳,获得10
1秒前
cdercder发布了新的文献求助10
1秒前
大马猴完成签到,获得积分10
3秒前
李敬语完成签到,获得积分10
3秒前
阿喵完成签到,获得积分10
4秒前
5秒前
和谐雁荷完成签到 ,获得积分10
5秒前
7秒前
duff完成签到 ,获得积分10
8秒前
zoey完成签到,获得积分20
8秒前
管恩杰发布了新的文献求助10
9秒前
zqf完成签到,获得积分10
9秒前
科学家发布了新的文献求助30
11秒前
SciGPT应助阿泽采纳,获得10
11秒前
来自天边云彩完成签到,获得积分10
12秒前
14秒前
浅斟低唱发布了新的文献求助10
14秒前
安安完成签到 ,获得积分10
14秒前
结实山水完成签到 ,获得积分10
15秒前
果粒儿完成签到 ,获得积分10
16秒前
Orange应助kiwi采纳,获得10
16秒前
17秒前
IfItheonlyone完成签到 ,获得积分10
17秒前
有机发布了新的文献求助10
18秒前
小豆芽完成签到,获得积分10
18秒前
xrrrr完成签到 ,获得积分10
23秒前
徐迎莹发布了新的文献求助10
24秒前
无花果应助浅斟低唱采纳,获得10
24秒前
bopop完成签到,获得积分10
26秒前
飘逸踏歌应助科研通管家采纳,获得10
27秒前
QOP应助科研通管家采纳,获得10
27秒前
SciGPT应助科研通管家采纳,获得10
27秒前
桐桐应助科研通管家采纳,获得10
27秒前
科研通AI2S应助科研通管家采纳,获得10
27秒前
在水一方应助科研通管家采纳,获得10
27秒前
QOP应助科研通管家采纳,获得10
27秒前
QOP应助科研通管家采纳,获得10
28秒前
今后应助科研通管家采纳,获得10
28秒前
桐桐应助科研通管家采纳,获得10
28秒前
28秒前
高分求助中
Continuum Thermodynamics and Material Modelling 2000
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
いちばんやさしい生化学 500
The First Nuclear Era: The Life and Times of a Technological Fixer 500
岡本唐貴自伝的回想画集 500
Atmosphere-ice-ocean interactions in the Antarctic 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3678145
求助须知:如何正确求助?哪些是违规求助? 3231616
关于积分的说明 9798640
捐赠科研通 2942801
什么是DOI,文献DOI怎么找? 1613538
邀请新用户注册赠送积分活动 761639
科研通“疑难数据库(出版商)”最低求助积分说明 737025